1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
611B95594D341732E652580BC00360636
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-managing-board-meetings-global-market?opendocument
18
19opendocument
2018.232.53.231
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services Business Operations Strategic Planning and Management

Best Practices in Managing Board Meetings in the Global Market

ID: PSM-338


Features:

10 Info Graphics

24 Data Graphics

160+ Metrics

5 Narratives

8 Best Practices


Pages: 47


Published: 2017


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Pharmaceutical advisory boards provide strategic inputs and guidance required to navigate through a complex regulatory labyrinth. With calls for greater transparency, it is important for healthcare leaders to devise effective strategies to conduct advisory boards and utilize advisory board feedback to add value across the development and marketing process.


Best Practices, LLC undertook benchmarking research to examine key trends in advisory board management, including the structure, planning, execution and utilization of advisory board feedback.


Industries Profiled:
Pharmaceutical; Biotech; Chemical; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Boehringer Ingelheim; Daiichi Sankyo; Gilead Sciences; Genentech; Pfizer; Sanofi; Shire; Teva Pharmaceutical Industries Ltd; UCB Pharma; ViiV Healthcare

Study Snapshot

Best Practices, LLC engaged 12 leaders with direct experience in the planning of Advisory Boards from 12 leading bio-pharmaceutical companies. About 70% of participants are at the level of director or above.

Key Findings

  • Company Size Impacts Number of Advisory Board Meetings Conducted: All companies with more than $10 billion in annual revenue last year conducted more than 100 Advisory Board meetings. Another 38% of companies, which are smaller and mid-size companies, conduct between 26 to 75 Advisory Board meetings each year.
  • Use of Advisory Board Feedback/Advice: 40% of the participants utilize feedback from advisory boards to develop future strategies, 30% protect the information, 20% utilize it based on the need, 10% plan execution and 10% set realistic expectation from advisory boards.
Table of Contents

I.Executive Summary pgs. 4-8
Research Overviewpg. 4
Participating Companies pg. 5
Key Findings & Insightspg. 6-7
Key Recommendationspgs. 8
II.Structure Of Advisory Boardspgs. 9-13
III.Planning For Advisory Boardspgs.14-25
IV.Execution Of Advisory Boardspgs. 26-29
V.Dissemination And Utilization Of Feedbackpgs. 30-41
VI.Appendix pgs. 42-45
VII.About Best Practices, LLC pgs. 46-47

    List of Charts & Exhibits

    • Total Advisory Board Meetings Conducted During the Last 12 months Across All Geographies and All Therapeutic Areas
    • Distribution of Advisory Boards in Different Categories – Medical, Commercial, Health Outcomes and Value & Access
    • Distribution of Advisory Boards - Single Country vs. Multi-country
    • Therapeutic Areas Supported by Advisory Boards
    • Methods and Factors Used for Planning Annual Advisory Board Meetings
    • Cross-Functional Teams Involved in Creating Annual Advisory Board Plan
    • Does a Governing Body or Specific Advisory Board Review the Plan to Ensure Strategy?
    • Process Employed To Review the Annual Advisory Board Plan
    • Use of Virtual Advisory Boards
    • Types of Advisory Boards Conducted within Participating Companies
    • Criteria Employed to Deploy Specific Advisory Board Meetings
    • Criteria Employed for Internal Staff to Attend an Advisory Board
    • Limit on the Number of Internal Staff Who Can Attend Advisory Board Meetings
    • Factors Impacting the Limit on Internal Staff
    • Confirmation of Number of Internal Staff Attending an Advisory Board
    • Limit on the Number of External Advisors Who Can Attend an Advisory Board Meeting
    • Ideal Ratio of Internal Staff to External Advisors
    • Granting Permission to Commercial Staff to Attend Medical Advisory Boards
    • How Does Your Company Execute an Advisory Board?
    • Do You Pay Advisors to Prepare for the Meeting (Prior to Advisory Board)?
    • Duration for Completion of Single and Multi-country Advisory Boards
    • Methods Used to Capture Advisory Board Feedback
    • Restriction on Sharing Feedback from a Medical Advisory Board
    • Storage of Advisory Board Feedback
    • Utilization of Feedback Internally and by Advisors
    • Circulation of Feedback to Advisors
    • Top Challenges for Conducting Advisory Boards
    • Best Practices in Conducting Advisory Boards